GE HealthCare Technologies Comprehensive Income 2020-2025 | GEHC
GE HealthCare Technologies comprehensive income from 2020 to 2025. Comprehensive income can be defined as the change in net assets of a business enterprise during a period from transactions and other events and circumstances from nonowner sources. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners.
- GE HealthCare Technologies comprehensive income for the quarter ending March 31, 2025 was $-1.379B, a 99.57% increase year-over-year.
- GE HealthCare Technologies comprehensive income for 2024 was $-1.379B, a 99.57% increase from 2023.
- GE HealthCare Technologies comprehensive income for 2023 was $-0.691B, a 63.21% decline from 2022.
- GE HealthCare Technologies comprehensive income for 2022 was $-1.878B, a 81.1% increase from 2021.
| GE HealthCare Technologies Annual Comprehensive Income (Millions of US $) |
|
|---|---|
| 2024 | $-1,379 |
| 2023 | $-691 |
| 2022 | $-1,878 |
| 2021 | $-1,037 |
| 2020 | $-839 |
| 2019 | $0 |
| GE HealthCare Technologies Quarterly Comprehensive Income (Millions of US $) |
|
|---|---|
| 2024-12-31 | $-1,379 |
| 2024-09-30 | $-771 |
| 2024-06-30 | $-845 |
| 2024-03-31 | $-787 |
| 2023-12-31 | $-691 |
| 2023-09-30 | $-280 |
| 2023-06-30 | $70 |
| 2023-03-31 | $75 |
| 2022-12-31 | $-1,878 |
| 2022-09-30 | $-1,942 |
| 2022-06-30 | |
| 2022-03-31 | |
| 2021-12-31 | |
| 2021-09-30 | |
| 2020-12-31 | |
| 2019-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $31.512B | $19.672B |
| Chicago, IL-based GE Healthcare is a leading maker of medical imaging and patient-monitoring products and related equipment and services. Approximately half of GE Healthcare's revenue comes from equipment sales, with consumables and services accounting for the other half. GE Healthcare started operating as an independent company after its January 2023 spin-off from General Electric (GE). | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $233.051B | 28.02 |
| Boston Scientific (BSX) | United States | $155.046B | 38.81 |
| Stryker (SYK) | United States | $146.591B | 30.65 |
| EssilorLuxottica (ESLOY) | France | $128.427B | 0.00 |
| Medtronic (MDT) | Ireland | $106.656B | 15.57 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.804B | 0.00 |
| Haleon (HLN) | United Kingdom | $48.530B | 27.59 |
| ResMed (RMD) | United States | $35.880B | 26.95 |
| Agilent Technologies (A) | United States | $30.654B | 20.25 |
| Terumo (TRUMY) | Japan | $28.279B | 0.00 |
| Koninklijke Philips (PHG) | Netherlands | $22.455B | 16.14 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.623B | 11.96 |
| Insulet (PODD) | United States | $18.597B | 79.37 |
| Baxter (BAX) | United States | $15.765B | 11.77 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.408B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $7.910B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.514B | 22.02 |
| Lantheus Holdings (LNTH) | United States | $5.512B | 14.05 |
| Prestige Consumer Healthcare (PBH) | United States | $4.033B | 19.25 |
| Perrigo (PRGO) | Ireland | $3.604B | 9.20 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| ICU Medical (ICUI) | United States | $3.310B | 28.20 |
| Haemonetics (HAE) | United States | $3.228B | 15.19 |
| Envista Holdings (NVST) | United States | $2.854B | 23.72 |
| GN Store Nord (GNNDY) | Denmark | $2.010B | 16.65 |
| LeMaitre Vascular (LMAT) | United States | $1.844B | 41.21 |
| QuidelOrtho (QDEL) | United States | $1.744B | 12.02 |
| AtriCure (ATRC) | United States | $1.500B | 0.00 |
| Neogen (NEOG) | United States | $1.287B | 16.47 |
| Green Thumb Industries (GTBIF) | United States | $1.274B | 28.67 |
| Kestra Medical Technologies (KMTS) | United States | $1.121B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.111B | 11.28 |
| BioLife Solutions (BLFS) | United States | $1.014B | 0.00 |
| InMode (INMD) | Israel | $0.989B | 9.06 |
| Phibro Animal Health (PAHC) | United States | $0.785B | 10.05 |
| Evolus (EOLS) | United States | $0.758B | 0.00 |
| Owens & Minor (OMI) | United States | $0.599B | 5.11 |
| CeriBell (CBLL) | United States | $0.577B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.565B | 0.00 |
| Valneva SE (VALN) | France | $0.551B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.539B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.435B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.411B | 0.00 |
| Surmodics (SRDX) | United States | $0.388B | 0.00 |
| Omeros (OMER) | United States | $0.370B | 0.00 |
| SNDL (SNDL) | Canada | $0.342B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.337B | 14.59 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.315B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.287B | 24.23 |
| Verano Holdings (VRNOF) | United States | $0.287B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.283B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.270B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.258B | 45.90 |
| Cerus (CERS) | United States | $0.249B | 0.00 |
| ZimVie (ZIMV) | United States | $0.248B | 14.83 |
| Canopy Growth (CGC) | Canada | $0.237B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.216B | 0.00 |
| Quanterix (QTRX) | United States | $0.208B | 0.00 |
| High Tide (HITI) | Canada | $0.192B | 0.00 |
| Biote (BTMD) | United States | $0.183B | 5.14 |
| Utah Medical Products (UTMD) | United States | $0.177B | 14.27 |
| TriSalus Life Sciences (TLSI) | United States | $0.168B | 0.00 |
| Brainsway (BWAY) | Israel | $0.164B | 51.24 |
| Organigram Global (OGI) | Canada | $0.150B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.149B | 18.39 |
| Jin Medical (ZJYL) | China | $0.126B | 0.00 |
| Exagen (XGN) | United States | $0.123B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.116B | 0.00 |
| MacroGenics (MGNX) | United States | $0.094B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.092B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.091B | 0.00 |
| Agape ATP (ATPC) | $0.086B | 0.00 | |
| Jushi Holdings (JUSHF) | United States | $0.083B | 0.00 |
| Fonar (FONR) | United States | $0.076B | 10.70 |
| Veru (VERU) | United States | $0.073B | 0.00 |
| InterCure (INCR) | Israel | $0.073B | 0.00 |
| Zynex (ZYXI) | United States | $0.063B | 0.00 |
| United Health Products (UEEC) | United States | $0.058B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.055B | 0.00 |
| Apyx Medical (APYX) | United States | $0.047B | 0.00 |
| ImmuCell (ICCC) | United States | $0.047B | 0.00 |
| Modular Medical (MODD) | United States | $0.042B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.038B | 56.00 |
| Safety Shot (SHOT) | United States | $0.037B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 11.24 |
| Nephros (NEPH) | United States | $0.021B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.012B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.011B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.011B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.007B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.004B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |